Advaxis, Inc.

General ticker "ADXS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $269.4K (TTM average)

Advaxis, Inc. follows the US Stock Market performance with the rate: 16.7%.

Estimated limits based on current volatility of 13.1%: low 0.10$, high 0.13$

Factors to consider:

  • Total employees count: 15 as of 2022
  • Top business risk factors: Integration of old and new ayala, Platform dependency, Regulatory and compliance, Labor/talent shortage/retention, Senior management dependency
  • Current price 79.3% below estimated low

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.44$, 1.84$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.50$, 1.99$]

Financial Metrics affecting the ADXS estimates:

  • Positive: with PPE of -0.1 at the end of fiscal year the price was low
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -738.18 <= 0.33
  • Positive: Investing cash flow per share per price, % of 148.86 > -0.66
  • Negative: negative Industry operating cash flow (median)
  • Negative: negative Net income

Similar symbols

Short-term ADXS quotes

Long-term ADXS plot with estimates

Financial data

YTD 2022-12-31 2023-12-31
Operating Revenue $0.25MM $0.01MM
Operating Expenses $16.34MM $36.28MM
Operating Income $-16.09MM $-36.27MM
Non-Operating Income $1.78MM $-15.72MM
R&D Expense $7.61MM $24.08MM
Income(Loss) $-14.31MM $-51.98MM
Taxes $0.05MM $-3.91MM
Profit(Loss)* $-14.36MM $-48.07MM
Stockholders Equity $23.63MM $-24.42MM
Assets $25.93MM $16.58MM
Operating Cash Flow $-34.51MM $-29.48MM
Investing Cash Flow $-0.00MM $5.95MM
Financing Cash Flow $-0.10MM $26.00MM
Earnings Per Share** $-7.90 $-7.99

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.